Filters

Anti-CSGALNACT1 (Polyclonal), ALEXA Fluor 594

Anti-CSGALNACT1 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Price 489
Size 100 microliters
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideCSGALNACT1
SpecificityThis antibody reacts specifically with CSGALNACT1
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human CSGALNACT1
Gene ID55790
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information Beta-1, Beta-1, Beta-1, Beta-1, Beta-1, GM1 and GD1a, Mice lacking the Beta-1, The Beta-1, a transmembrane region and a long C-terminal residue, coordination and balance, including deficits in reflexes, neuroblastoma and adult T cell leukemia, strength, such as malignant melanoma, which includes a catalytic domain and localizes to the Golgi apparatus, 4-GalNAc-T, 4-GalNAc-T is a potential molecular marker for detecting melanoma cells and monitoring tumor progression, 4-GalNAc-T is expressed in normal brain tissues and in various malignant transformed cells, 4-GalNAc-T protein consists of a short N-terminal residue, 4-GalNAc-T protein develop significant and progressive behavioral neuropathies, 4-GalNAc-T utilizes simple ganglioside GM3 as a substrate for more complex gangliosides GM2, 4-GalNAc-T2, 4-GalNAc-T3 and Beta-1, 4-GalNAc-T4, The chondroitin N-acetylgalactosaminyltransferase family includes Beta-1
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms CSGalNAcT-1 FLJ11264 ChGn
Also known asCSGALNACT1 Polyclonal Antibody
Other nameAnti-CSGALNACT1 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetCSGALNACT1
Short nameAnti-CSGALNACT1 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-CSGALNACT1 (polyclonal)
Alternative techniquepolyclonals
Identity 24290
Gene CSGALNACT1
Long gene name chondroitin sulfate N-acetylgalactosaminyltransferase 1
Synonyms name chondroitin beta1, 4 N-acetylgalactosaminyltransferase glucuronylgalactosylproteoglycan 4-beta-N- acetylgalactosaminyltransferase
Locus 8p21, 3
Discovery year 2008-02-26
GenBank acession AK002126
Entrez gene record 55790
Pubmed identfication 17145758 12446672
RefSeq identity NM_018371
Classification Beta 4-glycosyltransferases
Havana BLAST/BLAT OTTHUMG00000130827

Subscribe to our Newsletter